France· FR:61500746
ESPERAL 500 mg, comprimé
A medicinal product containing disulfirame, registered in France by NEURAXPHARM FRANCE, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- DISULFIRAME
- Manufacturer
- NEURAXPHARM FRANCE
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip133400930374696tube(s) polypropylène de 20 comprimé(s)EUR 1.8
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Disulfirame in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesDisulfiramSigmapharm Laboratories, LLC
- CzechiaTETRADIN
- United KingdomEsperal 500mg tabletsImported (France)
- PolandAnticolZakłady Farmaceutyczne POLPHARMA S.A.
- SwedenAntabus 200 mg BrustablettActavis Group PTC ehf.
- NorwayAntabusTeva B.V.
- NetherlandsAntabus dispergetten 400 mg, bruistablettenAurobindo Pharma B.V.
- ItalyETILTOX*30 cpr 200 mgMOLTENI & C. F.LLI ALITTI SpA
Authorised across Europe · EMA
The same active substance is authorised in 17 EEA countries. Names it is sold under:
- Czechia · Antabus
- Germany · Tetraethylthiuramdisulfid Smartpractice Europe
- Denmark · Antabus
- Spain · Antabus
- Finland · Antabus
- United Kingdom (Northern Ireland) · Antabuse, Disulfiram Accord-Uk
- Hungary · Antaethyl
- Ireland · Antabuse
- Iceland · Antabus
- Italy · Antabuse Dispergettes, Etiltox
- Malta · Disural
- Netherlands · Disulfiram Aurobindo, Refusal
- Norway · Antabus
- Poland · Anticol, Disulfiram Wzf
- Portugal · Tetradin
- Romania · Antalcol
- Sweden · Antabus
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/de0b269d-75a1-4f0d-935f-842b700ebfb3 GET /v1/drugs/de0b269d-75a1-4f0d-935f-842b700ebfb3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "61500746",
"date_amm": "1997-11-18",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "DISULFIRAME",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about disulfirame.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.